Ophirex received Wellcome Trust award to advance clinical development of novel snakebite treatment
On Mar. 2, 2020, Ophirex, a public-benefit biotechnology company working to improve outcomes for global victims of snakebite,…
-
-
Innovation Pharma provided scientific rationale and clinical development perspectives for Brilacidin as potential Coronavirus treatment
On Mar. 2, 2020, Innovation Pharma provided the scientific rationale and clinical development perspectives for Brilacidin, the Company’s…
-
Biotechnology | COVID-19 | Diagnostics | Life Science History | Non-Profit Research | Therapeutics | Vaccine
Boston University NEIDL scientists joined international Coronavirus research effort
On Mar. 2, 2020, Boston’s top infectious disease researchers, including scientists from Boston University’s National Emerging Infectious Diseases…
-
Gilead acquired Forty Seven for $49 billion in cash
On Mar. 2, 2020, Gilead Sciences announced it had acquired Forty Seven for $95.50 per share in cash…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine | WHO
UN released $15 million to help vulnerable countries battle the spread of the coronavirus
On Mar. 1, 2020, the United Nations Humanitarian Chief Mark Lowcock released US$15 million from the Central Emergency…
-
Mutations can reveal how the coronavirus moves, but they’re easy to overinterpret
On Feb. 28, 2020, immediately after Christian Drosten published a genetic sequence of the novel coronavirus online, he…
-
CDC | COVID-19 | Diagnostics | NIH | Therapeutics | Vaccine
COVID-19 a reminder of the challenge of emerging infectious diseases
On Feb. 28, 2020, commentary appeared in The New England Journal of Medicine that discussed the emergence and…
-
First-of-its-kind global collaboration launched to develop transformative treatment regimens for tuberculosis
On Feb. 27, 2020, a consortium of philanthropic, non-profit and private sector organisations launched a collaboration that aims…
-
Innovation Pharma shipped Brilacidin to U.S. Regional Biocontainment Laboratory for research against Coronavirus COVID-19
On Feb. 27, 2020, Innovation Pharma announced the Company had signed a Material Transfer Agreement (MTA) with one…
-
NIH announced $1 million prize competition to target global disease diagnostics
On Feb. 25, 2020, the U. S. National Institutes of Health (NIH) announced it had launched a $1…
-
Georgia Tech and Shriners Hospitals for Children announced new collaborative research affiliation
On Feb. 26, 2020, Georgia Institute of Technology and Shriners Hospitals for Children announced a collaborative research affiliation…
-
NIH clinical trial of remdesivir to treat COVID-19 began for adults with coronavirus disease
On Feb. 25, 2020, the National Institutes of Health (NIH) announced that a randomized, controlled clinical trial to…
-
Pilot clinical trial in China to test University of British Columbia researcher’s findings as a targeted therapy for COVID-19
On Feb. 25, 2020, a University of British Columbia (UBC) researcher was part of an international team working…
-
Vir Biotec and WuXi Biologics announced collaboration for global development of antibodies to treat COVID-19
On Feb. 25, 2020, Vir Biotech and WuXi Biologics announced a development and manufacturing collaboration to advance and…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
New technique helped uncover how Coronaviruses enter cells
On Feb. 24, 2020, researchers at National Institute of Allergy and Infectious Disease’s Rocky Mountain Laboratories in Hamilton,…
-
Texas Biomed established team to study SARS-CoV-2, new coronavirus
On Feb. 24, 2020, Scientists at Texas Biomed began work on the novel coronavirus known as SARS-CoV-2. A…
-
Biotechnology | Disease | FDA | Neurology | Pharmaceutical | Therapeutics
FDA approved Lundbeck’s VYEPTI™ – the first and only intravenous preventive treatment for migraine
On Feb. 21, 2020, Lundbeck announced that VYEPTI™ (eptinezumab-jjmr) had been approved by the U.S. Food and Drug…
-
COVID-19 coronavirus spike holds infectivity details
On Feb. 24, 2020, researchers reported that the spikes crowning the new coronavirus that causes COVID-19 atypical pneumonia…
-
The FDA approved non-statin drug to treat high cholesterol
On Feb. 21, 2020, the U.S. Food and Drug Administration (FDA) approved NEXLETOL (bempedoic acid) tablet, an oral,…
-
University of Missouri alumni gave $2 million gift to NextGen Precision Health Institute
On Feb. 21, 2020, a $2 million gift from University of Missouri alumni will support the university’s NextGen…
-
Biotechnology | Diagnostics | Disease | FDA | Therapeutics
FDA authorized marketing of first genetic test to aid in diagnosis of Fragile X Syndrome
On Feb. 21, 2020, the U.S. Food and Drug Administration (FDA) authorized marketing of the first test to…
-
Artificial intelligence yielded new antibiotic
On Feb. 20, 2020, using a machine-learning algorithm, researchers at MIT and the Broad Institute of MIT and…
-
Tim and Mary Boyle gave $10 million to OHSU for joint center for biomedical data science
On Feb. 20, 2020, Tim Boyle, CEO of Columbia Sportswear, and his wife, Mary, made a $10 million…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Therapeutics | Vaccine
NIH scientists identified atomic structure of novel Coronavirus protein
On Feb. 19, 2020, NIAID scientists working with investigators from the University of Texas at Austin identified the…
-
The CPRIT awarded 55 new grants totaling over $78 million
On Feb. 19, 2020, the Cancer Prevention & Research Institute of Texas (CPRIT) announced it had awarded 55…
-
First Swedish transplant of uterus from deceased donor
On Feb. 17, 2020, the University of Gothenburg announced that the team responsible for uterine transplantation research has,…
-
New, detailed molecular roadmap boosted fight against endometrial cancer
On Feb. 13, 2020, a study published in Cell provided an unprecedented look at the dozens of molecular…
-
Remdesivir prevented MERS coronavirus disease in monkeys
On Feb. 13, 2020, National Institutes of Health (NIH) scientists announced that the experimental antiviral remdesivir successfully prevented…
-
Vir Biotec identified two antibodies that bind to spike protein of SARS-CoV-2
On Feb. 12, 2020, Vir Biotech announced it had identified two monoclonal antibodies (mAbs) that bind to SARS-CoV-2…
-
The Pan-cancer analysis of whole genomes was published in Nature
On Feb. 5, 2020, The Pan-cancer analysis of whole genomes was published in Nature. The flagship paper of…
